The chemotherapy of malignant diseases: research perspectives
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Basel ; München [u.a.]
Karger
1989
|
Schriftenreihe: | Beiträge zur Onkologie
34 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Literaturverz. S. [108] - 154 |
Beschreibung: | VIII, 154 S. Ill., graph. Darst. |
ISBN: | 3805549652 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV001877546 | ||
003 | DE-604 | ||
005 | 20130624 | ||
007 | t | ||
008 | 890814s1989 ad|| |||| 00||| eng d | ||
020 | |a 3805549652 |9 3-8055-4965-2 | ||
035 | |a (OCoLC)20574658 | ||
035 | |a (DE-599)BVBBV001877546 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-12 |a DE-355 |a DE-29 |a DE-188 |a DE-578 | ||
050 | 0 | |a RC271.C5 | |
082 | 0 | |a 616.99/4061 |2 20 | |
084 | |a VS 9100 |0 (DE-625)147725:253 |2 rvk | ||
084 | |a XH 1500 |0 (DE-625)152870:12905 |2 rvk | ||
084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
245 | 1 | 0 | |a The chemotherapy of malignant diseases |b research perspectives |c H. H. Sedlacek ... |
264 | 1 | |a Basel ; München [u.a.] |b Karger |c 1989 | |
300 | |a VIII, 154 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Beiträge zur Onkologie |v 34 | |
500 | |a Literaturverz. S. [108] - 154 | ||
650 | 4 | |a Antineoplastic Agents |x therapeutic use | |
650 | 4 | |a Antineoplastic agents |x Testing | |
650 | 4 | |a Cancer |x Chemotherapy | |
650 | 4 | |a Neoplasms |x drug therapy | |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Tumor |0 (DE-588)4078460-5 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Tumor |0 (DE-588)4078460-5 |D s |
689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Sedlacek, Hans-Harald |d 1943- |e Sonstige |0 (DE-588)1029511926 |4 oth | |
830 | 0 | |a Beiträge zur Onkologie |v 34 |w (DE-604)BV000000016 |9 34 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001238714&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-001238714 |
Datensatz im Suchindex
_version_ | 1804116337658691584 |
---|---|
adam_text | Q THE CHEMOTHERAPY OF MALIGNANT DISEASES RESEARCH PERSPECTIVES H. H.
SEDLACEK, D. HOFFMANN, G. SCHULZ, J. CZECH, B. GREIFENBERG, G.
DICKNEITE, H.-P. KRAEMER, MARBURG 10 FIGURES AND 34 TABLES, 1989 BASEL *
MUENCHEN * PARIS * LONDON * NEW YORK * NEW DELHI * SINGAPORE * TOKYO *
SYDNEY CONTENTS PREFACE VII ACKNOWLEDGEMENTS IX I. INTRODUCTION 1 II.
CYTOSTATICS 4 SCREENING SYSTEMS 4 DRUG RESISTANCE 16 PHARMACOKINETIC
PARAMETERS 26 ROUTE OF APPLICATION 26 SLOW-RELEASE FORMS 31 LIPOSOMES 31
NANOPARTICLES 40 COMBINATION TREATMENT 43 CLINICAL EXPERIENCE 43
CONCLUSIONS AND PERSPECTIVES 47 PRETHERAPEUTIC CHEMOSENSITIVITY TESTING
ON HUMAN TUMORS 49 CONCEPTIONAL BASIS 50 TEST SYSTEMS 53 CLONOGENIC
ASSAY ,53 ANTIMETABOLIC ASSAY 54 DYE EXCLUSION ASSAY 55 CLINICAL
CORRELATIONS 56 FUTURE PROSPECTS 59 III. PREVENTION AND TREATMENT OF
ORGAN-DIRECTED TOXICITIES OF CYTOSTATICS 61 KIDNEY, BLADDER, HEART, LUNG
61 BONE MARROW 64 RATIONALE AND BACKGROUND 64 REGULATION OF THE
HEMATOPOIETIC SYSTEM BY COLONY STIMULATING FACTORS (CSFS) 65
EXPERIMENTAL STUDIES WITH CSFS 68 MOLECULAR CLONING OF HUMAN CSFS 68 CSF
GENE EXPRESSION 69 FUNCTIONAL STUDIES WITH CSFS IN VITRO AND IN ANIMALS
70 CONTENTS VI CLINICAL EXPERIENCE WITH CSFS 73 GM-CSF AND G-CSF IN
PATIENTS WITH REFRACTORY CANCER 73 GM-CSF IN PATIENTS WITH
MYELODYSPLASTIC SYNDROMES, ACUTE NON- LYMPHOCYTIC LEUKEMIA AND APLASTIC
ANEMIA 76 CSFS IN PATIENTS AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION
78 FUTURE POSSIBILITIES FOR THE CLINICAL USE OF CSFS 80 IV. INHIBITORS
FOR HORMONES 81 ANTIESTROGENS 81 GROWTH FACTORS AND INHIBITORS 87 V.
INHIBITION OF TUMOR CELL PENETRATION AND METASTASIS 97 VI.
DIFFERENTIATION OF TUMOR CELLS 101 VII. CONCLUSIONS 106 REFERENCES 108
AUTHORS ADDRESSES 154
|
any_adam_object | 1 |
author_GND | (DE-588)1029511926 |
building | Verbundindex |
bvnumber | BV001877546 |
callnumber-first | R - Medicine |
callnumber-label | RC271 |
callnumber-raw | RC271.C5 |
callnumber-search | RC271.C5 |
callnumber-sort | RC 3271 C5 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | VS 9100 XH 1500 XH 3200 |
ctrlnum | (OCoLC)20574658 (DE-599)BVBBV001877546 |
dewey-full | 616.99/4061 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.99/4061 |
dewey-search | 616.99/4061 |
dewey-sort | 3616.99 44061 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02046nam a2200517 cb4500</leader><controlfield tag="001">BV001877546</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130624 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890814s1989 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805549652</subfield><subfield code="9">3-8055-4965-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)20574658</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV001877546</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9100</subfield><subfield code="0">(DE-625)147725:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1500</subfield><subfield code="0">(DE-625)152870:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The chemotherapy of malignant diseases</subfield><subfield code="b">research perspectives</subfield><subfield code="c">H. H. Sedlacek ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel ; München [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 154 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Beiträge zur Onkologie</subfield><subfield code="v">34</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. [108] - 154</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sedlacek, Hans-Harald</subfield><subfield code="d">1943-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1029511926</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Beiträge zur Onkologie</subfield><subfield code="v">34</subfield><subfield code="w">(DE-604)BV000000016</subfield><subfield code="9">34</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001238714&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001238714</subfield></datafield></record></collection> |
id | DE-604.BV001877546 |
illustrated | Illustrated |
indexdate | 2024-07-09T15:36:55Z |
institution | BVB |
isbn | 3805549652 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001238714 |
oclc_num | 20574658 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-29 DE-188 DE-578 |
owner_facet | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-29 DE-188 DE-578 |
physical | VIII, 154 S. Ill., graph. Darst. |
publishDate | 1989 |
publishDateSearch | 1989 |
publishDateSort | 1989 |
publisher | Karger |
record_format | marc |
series | Beiträge zur Onkologie |
series2 | Beiträge zur Onkologie |
spelling | The chemotherapy of malignant diseases research perspectives H. H. Sedlacek ... Basel ; München [u.a.] Karger 1989 VIII, 154 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Beiträge zur Onkologie 34 Literaturverz. S. [108] - 154 Antineoplastic Agents therapeutic use Antineoplastic agents Testing Cancer Chemotherapy Neoplasms drug therapy Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Tumor (DE-588)4078460-5 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Chemotherapie (DE-588)4127083-6 s DE-604 Tumor (DE-588)4078460-5 s Sedlacek, Hans-Harald 1943- Sonstige (DE-588)1029511926 oth Beiträge zur Onkologie 34 (DE-604)BV000000016 34 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001238714&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | The chemotherapy of malignant diseases research perspectives Beiträge zur Onkologie Antineoplastic Agents therapeutic use Antineoplastic agents Testing Cancer Chemotherapy Neoplasms drug therapy Krebs Medizin (DE-588)4073781-0 gnd Chemotherapie (DE-588)4127083-6 gnd Tumor (DE-588)4078460-5 gnd |
subject_GND | (DE-588)4073781-0 (DE-588)4127083-6 (DE-588)4078460-5 |
title | The chemotherapy of malignant diseases research perspectives |
title_auth | The chemotherapy of malignant diseases research perspectives |
title_exact_search | The chemotherapy of malignant diseases research perspectives |
title_full | The chemotherapy of malignant diseases research perspectives H. H. Sedlacek ... |
title_fullStr | The chemotherapy of malignant diseases research perspectives H. H. Sedlacek ... |
title_full_unstemmed | The chemotherapy of malignant diseases research perspectives H. H. Sedlacek ... |
title_short | The chemotherapy of malignant diseases |
title_sort | the chemotherapy of malignant diseases research perspectives |
title_sub | research perspectives |
topic | Antineoplastic Agents therapeutic use Antineoplastic agents Testing Cancer Chemotherapy Neoplasms drug therapy Krebs Medizin (DE-588)4073781-0 gnd Chemotherapie (DE-588)4127083-6 gnd Tumor (DE-588)4078460-5 gnd |
topic_facet | Antineoplastic Agents therapeutic use Antineoplastic agents Testing Cancer Chemotherapy Neoplasms drug therapy Krebs Medizin Chemotherapie Tumor |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=001238714&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV000000016 |
work_keys_str_mv | AT sedlacekhansharald thechemotherapyofmalignantdiseasesresearchperspectives |